SiRNA - Gettling the message out

被引:27
作者
Lee, SH [1 ]
Sinko, PJ [1 ]
机构
[1] Rutgers State Univ, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA
关键词
transporters; drug transport; silencer RNA; gene silencing; siRNA; gene knockdown;
D O I
10.1016/j.ejps.2005.12.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The recent observation that potent and sequence-specific gene silencing by injection of double-stranded RNA (dsRNA) has sparked the phenomenon known as "RNA interference" (RNAi) and has enabled the gene-specific knockdown of drug transport proteins and metabolizing enzymes. The application of small interfering RNAs (siRNAs) is broad and the potential for use as research tools is now well established in vitro. In vivo use is still a challenge that is primarily focused on the difficulty of delivering siRNAs to target cells. The potential use of siRNAs as therapeutic agents is also exciting and holds great promise for future. For the study of drug transporter function in absorption, distribution, metabolism and excretion (ADME) and in the treatment of diseases, siRNA offers a way to gather interpretable mechanistic data-a distinct advantage over the use of "specific" chemical inhibitors. This mini review provides background information on siRNA as well as examples of the use of siRNA as applied to drug transporters. (c) 2006 Published by Elsevier B.V.
引用
收藏
页码:401 / 410
页数:10
相关论文
共 69 条
[1]  
Allen JD, 1999, CANCER RES, V59, P4237
[2]   Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening [J].
Aza-Blanc, P ;
Cooper, CL ;
Wagner, K ;
Batalov, S ;
Deveraux, QL ;
Cooke, MP .
MOLECULAR CELL, 2003, 12 (03) :627-637
[3]   A large-scale RNAi screen in human cells identifies new components of the p53 pathway [J].
Berns, K ;
Hijmans, EM ;
Mullenders, J ;
Brummelkamp, TR ;
Velds, A ;
Heimerikx, M ;
Kerkhoven, RM ;
Madiredjo, M ;
Nijkamp, W ;
Weigelt, B ;
Agami, R ;
Ge, W ;
Cavet, G ;
Linsley, PS ;
Beijersbergen, RL ;
Bernards, R .
NATURE, 2004, 428 (6981) :431-437
[4]  
Bi Feng, 2003, Current Gene Therapy, V3, P411, DOI 10.2174/1566523034578203
[5]   Efficient gene transfer of HIV-1-specific short hairpin RNA into human lymphocytic cells using recombinant adeno-associated virus vectors [J].
Boden, D ;
Pusch, O ;
Lee, F ;
Tucker, L ;
Ramratnam, B .
MOLECULAR THERAPY, 2004, 9 (03) :396-402
[6]   Mechanistic insights aid computational short interfering RNA design [J].
Boese, Q ;
Leake, D ;
Reynolds, A ;
Read, S ;
Scaringe, SA ;
Marshall, WS ;
Khvorova, A .
RNA INTERFERENCE, 2005, 392 :73-+
[7]   Stable suppression of tumorigenicity by virus-mediated RNA interference [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
CANCER CELL, 2002, 2 (03) :243-247
[8]   Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB [J].
Brummelkamp, TR ;
Nijman, SMB ;
Dirac, AMG ;
Bernards, R .
NATURE, 2003, 424 (6950) :797-801
[9]   RNAI as an experimental and therapeutic tool to study and regulate physiological and disease processes [J].
Dillon, CP ;
Sandy, P ;
Nencioni, A ;
Kissler, S ;
Rubinson, DA ;
Van Parijs, L .
ANNUAL REVIEW OF PHYSIOLOGY, 2005, 67 :147-173
[10]   Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis [J].
Ding, HL ;
Schwarz, DS ;
Keene, A ;
Affar, EB ;
Fenton, L ;
Xia, XA ;
Shi, Y ;
Zamore, PD ;
Xu, ZS .
AGING CELL, 2003, 2 (04) :209-217